Murder through the Looking Glass: Gillon v HM Advocate.

Autor: Chalmers, James¹, Leverick, Fiona²

Publikováno v: Edinburgh Law Review. May2007, Vol. 11 Issue 2, p230-236. 7p.

Bench v Bar: Contempt of Court and the New Zealand Legal Profession in Gillon v MacDonald (1878)

Autor: Grant Hamilton Morris

Publikováno v: Victoria University of Wellington Law Review. 41:541-562

Gillon v MacDonald (1878) was the climax of a feud that caused division in, and undermined the reputation of, the early New Zealand legal profession. Gillon features one of the most controversial episodes of contempt of court by a barrister in coloni

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::976f573c1bc4d1125bcce40ee727f59a
https://doi.org/10.26686/vuwlr.v41i3.5216

Application of Machine Learning Prediction of Individual SARS-CoV-2 Vaccination and Infection Status to the French Serosurveillance Survey From March 2020 to 2022: Cross-Sectional Study.

Autor: Bougeard S; Epidemiology, Health and Welfare, Laboratory of Ploufragan-Plouzané-Niort, French Agency for Food, Environmental, Occupational Health & Safety, Ploufragan, France., Huneau-Salaun A; Epidemiology, Health and Welfare, Laboratory of Ploufragan-Plouzané-Niort, French Agency for Food, Environmental, Occupational Health & Safety, Ploufragan, France., Attia M; Unit of Molecular Genetics of RNA Viruses, Institut Pasteur, Paris, France., Richard JB; Data Support, Processing and Analysis Department, Santé publique France, Saint-Maurice, France., Demeret C; Unit of Molecular Genetics of RNA Viruses, Institut Pasteur, Paris, France., Platon J; Data Support, Processing and Analysis Department, Santé publique France, Saint-Maurice, France., Allain V; Epidemiology, Health and Welfare, Laboratory of Ploufragan-Plouzané-Niort, French Agency for Food, Environmental, Occupational Health & Safety, Ploufragan, France., Le Vu S; EPI-PHARE, Saint-Denis, France., Goyard S; Diagnostic Test Innovation and Development Core Facility, Institut Pasteur, Paris, France., Gillon V; Clinical Immunology Laboratory, Institut Curie, Paris, France., Bernard-Stoecklin S; Infectious Disease Division, Santé publique France, Saint-Maurice, France., Crescenzo-Chaigne B; Unit of Molecular Genetics of RNA Viruses, Institut Pasteur, Paris, France., Jones G; Infectious Disease Division, Santé publique France, Saint-Maurice, France., Rose N; Epidemiology, Health and Welfare, Laboratory of Ploufragan-Plouzané-Niort, French Agency for Food, Environmental, Occupational Health & Safety, Ploufragan, France., van der Werf S; Unit of Molecular Genetics of RNA Viruses, Institut Pasteur, Paris, France., Lantz O; Clinical Immunology Laboratory, Institut Curie, Paris, France., Rose T; Diagnostic Test Innovation and Development Core Facility, Institut Pasteur, Paris, France., Noël H; Infectious Disease Division, Santé publique France, Saint-Maurice, France.

Publikováno v: JMIR public health and surveillance [JMIR Public Health Surveill] 2023 Nov 28; Vol. 9, pp. e46898. Date of Electronic Publication: 2023 Nov 28.

High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris.

Autor: Anna F; Theravectys, Paris, France., Goyard S; Unit of Lymphocyte Cell Biology, Immunology Department, Institut Pasteur, Paris, France.; INSERM 1221, Institut Pasteur, Paris, France., Lalanne AI; Laboratoire d'Immunologie Clinique, Institut Curie, Paris, France.; Centre d'Investigation Clinique en Biothérapie (CIC-BT1428), Institut Curie, Paris, France., Nevo F; Theravectys, Paris, France., Gransagne M; Innovation Laboratory: Vaccines, Institut Pasteur, Paris, France., Souque P; Unit of Molecular Virology and Vaccinology, Virology Department, Institut Pasteur, Paris, France., Louis D; Laboratoire d'Immunologie Clinique, Institut Curie, Paris, France.; Centre d'Investigation Clinique en Biothérapie (CIC-BT1428), Institut Curie, Paris, France., Gillon V; Direction of the Clinical Research, Institut Curie, Paris, France., Turbiez I; Direction of the Clinical Research, Institut Curie, Paris, France., Bidard FC; Centre d'Investigation Clinique en Biothérapie (CIC-BT1428), Institut Curie, Paris, France.; Medical Oncology Department, Institut Curie, Paris, France.; UVSQ, Paris-Saclay University, Saint-Cloud, France., Gobillion A; Biometry, Institut Curie, Paris, France., Savignoni A; Biometry, Institut Curie, Paris, France., Guillot-Delost M; Centre d'Investigation Clinique en Biothérapie (CIC-BT1428), Institut Curie, Paris, France.; INSERM U932, PSL University, Institut Curie, Paris, France., Dejardin F; Production and Purification of Recombinant Proteins Technological Platform, Institut Pasteur, Paris, France., Dufour E; Production and Purification of Recombinant Proteins Technological Platform, Institut Pasteur, Paris, France., Petres S; Production and Purification of Recombinant Proteins Technological Platform, Institut Pasteur, Paris, France., Richard-Le Goff O; Unit of Antibody in Therapy and Pathology, Institut Pasteur, Paris, France., Choucha Z; Innovation Laboratory: Vaccines, Institut Pasteur, Paris, France., Helynck O; Unit of Chemistry and Biocatalysis, Institut Pasteur, CNRS UMR 3523, Paris, France., Janin YL; Unit of Chemistry and Biocatalysis, Institut Pasteur, CNRS UMR 3523, Paris, France., Escriou N; Innovation Laboratory: Vaccines, Institut Pasteur, Paris, France., Charneau P; Theravectys, Paris, France.; Unit of Molecular Virology and Vaccinology, Virology Department, Institut Pasteur, Paris, France., Perez F; Cell Biology and Cancer Unit, Institut Curie, CNRS UMR 144, PSL Research University, Paris, France., Rose T; Unit of Lymphocyte Cell Biology, Immunology Department, Institut Pasteur, Paris, France.; INSERM 1221, Institut Pasteur, Paris, France., Lantz O; Laboratoire d'Immunologie Clinique, Institut Curie, Paris, France.; Centre d'Investigation Clinique en Biothérapie (CIC-BT1428), Institut Curie, Paris, France.; INSERM U932, PSL University, Institut Curie, Paris, France.

Publikováno v: European journal of immunology [Eur J Immunol] 2021 Jan; Vol. 51 (1), pp. 180-190. Date of Electronic Publication: 2020 Dec 23.

Characterization of Antineoplastic Agents Inducing Taste and Smell Disorders Using the FAERS Database.

Autor: Hamazaki, Risa¹ (AUTHOR), Uesawa, Yoshihiro¹ (AUTHOR) uesawa@my-pharm.ac.jp

Publikováno v: Pharmaceuticals (14248247). Sep2024, Vol. 17 Issue 9, p1116. 15p.